2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]thio]-1H-benzimidazole → HCID 178431607, 화합물

HRID 1033739노트

반응식

HRID 1033739 반응식
C[O:2][C:3]1[CH:8]=[CH:7][N:6]=[C:5]([CH2:9][S:10][C:11]2[NH:12][C:13]3[CH:19]=[CH:18][CH:17]=[CH:16][C:14]=3[N:15]=2)[C:4]=1[CH3:20]>Br>[OH:2][C:3]1[CH:8]=[CH:7][N:6]=[C:5]([CH2:9][S:10][C:11]2[NH:15][C:14]3[CH:16]=[CH:17][CH:18]=[CH:19][C:13]=3[N:12]=2)[C:4]=1[CH3:20]

참가 물질

3

반응물 1

HCID 108030672-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]thio]-1H-benzimidazole

생성물 1

HCID 178431607HCID 178431607, 화합물수율 68.4%

시약·촉매·용매 1

HCID 260Hydrogen Bromide용매

실험 절차

A solution of 2-[(4-methoxy-3-methyl-2-pyridyl) methylthio]benzimidazole (16.6 g) in 47% aqueous solution of HBr (250 ml) was heated for 24 hours under reflux. The reaction mixture was concentrated under reduced pressure. The concentrate was neutralized with a saturated aqueous solution of sodium hydrogencarbonate. The oily portion was separated and subjected to a silica gel column chromatography, eluting with chloroform-methanol (25:2, v/v), to give 2-[(4-hydroxy-3-methyl-2-pyridyl)methylthio]benzimidazole (10.8 g) as colorless powder. 1H-NMR(δ ppm in CDCl3): 2.12(3H,s), 4.38(2H,s), 6.43(1H,d,J=7Hz), 7.1-7.3(2H,m), 7.4-7.6(3H,m)

후처리

  1. temperatureunder reflux
  2. concentrationThe reaction mixture was concentrated under reduced pressure
  3. customThe oily portion was separated
  4. washeluting with chloroform-methanol (25:2

출처 및 근거

ORD 기록
ord-690521f704704beca8155296990c8d5e
출처 데이터셋
uspto-grants-1994_05
특허 번호
US05312824

반응 노트

불러오는 중…